IRIX — IRIDEX CORP

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1006045 ·
Last close
$1.04
Market Cap
$18.10M
52W High
$1.45
52W Low
$0.95
ADV30
64,778
Next earnings
2026-08-18
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 11,799,000 4,741,000 -324,000 -524,000 28,274,000 4,595,000 23,542,000
Dec 2025 14,724,000 5,477,000 -15,000 -184,000 29,151,000 6,028,000 24,229,000
Sep 2025 12,484,000 4,013,000 -1,411,000 -1,573,000 28,353,000 5,573,000 23,672,000
Jun 2025 13,571,000 4,682,000 -940,000 -994,000 31,585,000 6,778,000 25,526,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-2,115,000
Investing CF
$-143,000
Financing CF
$5,964,000
CapEx
$-143,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.26
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-92,446,000
Inventory
$7,877,000
Receivables
$9,545,000
ST Investments
EBIT TTM
$-2,571,000
Pretax Income TTM
$-4,380,000
Interest Exp TTM
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$52,578,000
EBITDA
$-2,474,000
Free Cash Flow
$990,750
Enterprise Value
$23,261,584
Total Cash
$4,595,000
Total Debt
$4,276,000
Shares Out
17,406,518
Trailing EPS
$-0.19
Book Value
$-0.06
ROE
-56.5%
ROA
-5.4%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 52,675,000 -2,571,000 -4,437,000 29,151,000 24,229,000 -2,115,000
Dec 2024 48,669,000 -8,302,000 -8,910,000 29,135,000 27,038,000 -7,285,000
Dec 2023 51,869,000 -10,007,000 -9,570,000 34,436,000 24,914,000 -6,745,000
Dec 2022 56,972,000 -7,542,000 -7,547,000 42,290,000 25,059,000 -9,519,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$0.02

Peers — same industry

TickerNameMarket CapLastDaily %
GTHP GUIDED THERAPEUTICS INC $18.34M $0.19
ICCM IceCure Medical Ltd. $18.40M $0.23
OSRH OSR Holdings, Inc. $17.38M $0.50
LFWD Lifeward Ltd. $19.39M $6.98
ADGM Adagio Medical Holdings, Inc. $16.66M $0.75

News headlines (Yahoo Finance, 1h cache)

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth
2026-05-25 16:59 · Yahoo
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
2026-05-20 05:00 · Yahoo
IRIDEX Corporation Q1 2026 Earnings Call Summary
2026-05-20 00:31 · Yahoo
Iridex Reports First Quarter 2026 Financial Results
2026-05-19 20:05 · Yahoo
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
2026-05-05 20:05 · Yahoo
Top Analyst Reports for Microsoft, AbbVie & BHP
2026-04-17 21:16 · Yahoo
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
2026-04-07 20:05 · Yahoo
Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth
2026-04-01 17:23 · Yahoo
IRIDEX Corporation Q4 2025 Earnings Call Summary
2026-03-27 00:16 · Yahoo
IRIDEX (IRIX) Q4 2025 Earnings Call Transcript
2026-03-26 21:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.